Is SGBI or EPRT a better dividend investment in 2026?

SGBI currently yields 1000000.00% with a 5% 5-year dividend growth rate. EPRT yields 3.97% with 5% growth. The better choice depends on your goal: SGBI offers higher current income.

What is the dividend yield difference between SGBI and EPRT?

SGBI has a forward dividend yield of 1000000.00% ($2.00/share annually). EPRT yields 3.97% ($1.21/share annually). The yield gap is 999996.03 percentage points.

Home › Compare › SGBI vs EPRT

SGBI vs EPRT: Dividend Comparison 2026

SGBI yields 1000000.00% · EPRT yields 3.97%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SGBI wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SGBI

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full SGBI calculator →

EPRT

● Live price

3.97%

Share price

$30.36

Annual div

$1.21

5Y div CAGR

29%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$64.3K

Annual income

$13,170.85

Full EPRT calculator →

Portfolio growth — SGBI vs EPRT

📍 SGBI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SGBI	EPRT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SGBI + EPRT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SGBI pays

EPRT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGBI

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

EPRT

Annual income on $10K today (after 15% tax)

$337.37/yr

After 10yr DRIP, annual income (after tax)

$11,195.22/yr

At 15% tax rate, SGBI beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGBI + EPRT for your $10,000?

SGBI: 50%EPRT: 50%

100% EPRT50/50100% SGBI

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SGBI

No analyst data

Altman Z

-342.5

Piotroski

7/9

EPRT

Analyst Ratings

Strong

Buy

Hold

Sell

Consensus: Buy

Price Target

$35.50

+16.9% upside vs current

Range: $33.00 — $37.00

Altman Z

1.8

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGBI buys

EPRT buys

No recent congressional trades found for SGBI or EPRT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSGBIEPRT

Forward yield	1000000.00% ✓	3.97%
Annual dividend / share	$2.00 ✓	$1.21
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	29% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$64.3K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$13,170.85
Total dividends collected	$4.7683311610149396e+36M	$38.7K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: SGBI vs EPRT ($10,000, DRIP)

Year	SGBI Portfolio	SGBI Income/yr	EPRT Portfolio	EPRT Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,212	$512.01	+$100.00M → SGBI
2	$934,786,450,701	$934,679,439,252.34	$12,689	$692.09	+$934786.44M → SGBI
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$14,521	$944.30	+$8165787108.56M → SGBI
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$16,841	$1,302.88	+$66665884190957.63M → SGBI
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$19,841	$1,821.64	+$508662171058048128.00M → SGBI
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$23,818	$2,587.47	+$3.62723524842849e+21M → SGBI
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$29,230	$3,744.65	+$2.417368115915061e+25M → SGBI
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$36,816	$5,540.38	+$1.5056740286145463e+29M → SGBI
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$47,806	$8,413.17	+$8.764771002818475e+32M → SGBI
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$64,324	$13,170.85	+$4.7683925249533696e+36M → SGBI

SGBI vs EPRT: Complete Analysis 2026

SGBI — Stock

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Full SGBI Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →

📬

Get this SGBI vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGBI vs SCHD SGBI vs JEPI SGBI vs O SGBI vs KO SGBI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.